By Kelvin Prescott | Friday 30 December 2016
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I wrote in May of this year that the price of Port Erin Biopharma (PEBI) was trading at a large enough discount to Net Asset Value that it was worth taking a position. At the time, it was trading in the 4-4.5p range; its now at 5.625p in the middle but with a pretty wide spread. But it is time to sell because the facts have changed substantially.
Filed under:
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Time left: 15:09:16